Tag: medical device

Legislation introduced this Session – HB 95 and SB 182 – seeks to change the current drug formulary system utilized by health insurers and pharmacy benefit managers. Both bills have received significant support from “patient advocacy groups” during the course of the debate. But who are these so-called patient groups, and how are they funded? […]